Inhibrx Biosciences, Inc. (INBX)
NASDAQ:INBX
Inhibrx Biosciences Inc (INBX) Ownership Overview
9.74% Insiders
8.48% Mutual Funds
46.68% Other Institutional Investors
9.09% ETFs
26.01% Public Companies and
Individual Investors
The ownership structure of Inhibrx Biosciences Inc (INBX) stock is a mix of institutional, retail, and individual investors. Approximately 64.25% of the company’s stock is owned by Institutional Investors, 9.74% is owned by Insiders, and 26.01% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Oct 09, 2025 | xxxxxxxxxxxxx | $11287500 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Dec 31, 2025 | xxxxxxxxxxxxx | $11018841 | |
Dec 31, 2025 | xxxxxxxxxxxxx | $113578695 | |
Dec 31, 2025 | xxxxxxxxxxxxx | $114763853 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,452,707 | Institution | 9.99% | 101,268,205 | |
| 1,437,705 | Institution | 9.89% | 100,222,416 | |
| 1,059,046 | Insider | 7.28% | 73,826,097 | |
| 541,995 | Institution | 3.73% | 37,782,471 | |
| 467,561 | Institution | 3.21% | 32,593,677 | |
| 441,468 | Institution | 3.04% | 30,774,734 | |
| 380,217 | Institution | 2.61% | 26,504,927 | |
| 224,564 | Insider | 1.54% | 15,654,356 | |
| 193,023 | Institution | 1.33% | 13,455,633 | |
| 139,479 | Institution | 0.96% | 9,723,081 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 467,561 | Institution | 3.21% | 32,593,677 | |
| 380,217 | Institution | 2.61% | 26,504,927 | |
| 102,120 | Institution | 0.70% | 7,118,785 | |
| 90,720 | Institution | 0.62% | 6,324,091 | |
| 51,016 | Institution | 0.35% | 3,556,325 | |
| 28,212 | Institution | 0.19% | 1,966,659 | |
| 27,793 | Institution | 0.19% | 1,937,450 | |
| 16,736 | Institution | 0.12% | 1,166,667 | |
| 13,541 | Institution | 0.09% | 943,943 | |
| 9,000 | Institution | 0.06% | 627,390 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 363,841 | Institution | 2.50% | 27,750,153 | |
| 223,962 | Institution | 1.54% | 15,612,391 | |
| 135,798 | Institution | 0.93% | 9,405,369 | |
| 103,519 | Institution | 0.71% | 7,895,394 | |
| 79,382 | Institution | 0.55% | 5,533,719 | |
| 73,925 | Institution | 0.51% | 5,153,312 | |
| 46,595 | Institution | 0.32% | 3,202,940 | |
| 44,966 | Institution | 0.31% | 3,333,330 | |
| 40,361 | Institution | 0.28% | 2,813,565 | |
| 37,605 | Institution | 0.26% | 2,604,522 |
FAQ
Who Owns Inhibrx Biosciences, Inc. (INBX)?
According to the latest TipRanks data, approximately 46.68% of the company's stock is held by institutional investors, 9.74% is held by insiders, and 26.01% is held by retail investors.
What percentage of Inhibrx Biosciences, Inc. (INBX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 46.68% of Inhibrx Biosciences, Inc. (INBX) stock is held by institutional investors.
What percentage of Inhibrx Biosciences, Inc. (INBX) stock is held by retail investors?
According to the latest TipRanks data, approximately 26.01% of Inhibrx Biosciences, Inc. (INBX) stock is held by retail investors.
Who owns the most shares of Inhibrx Biosciences, Inc. (INBX)?
Joseph Edelman owns the most shares of Inhibrx Biosciences, Inc. (INBX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.